About Koronis
Koronis is a company based in Zirakpur (India) founded in 2013. Koronis offers products and services including Health Products and Environmental Services.
- Headquarter Zirakpur, India
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Legal Name Koronis Pharmaceutical Private Limited
- Date of Incorporation 08 Nov, 2011
- Jurisdiction Silchar, Assam, India
- Annual Revenue₹1.93 Cr
FY 2023 · +9% YoY
- Net Profit₹0.06 Cr
FY 2023 · 3% margin
- EBITDA₹0.10 Cr
FY 2023 · 5% margin
Associated legal entities of Koronis
Koronis operates through Koronis Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Koronis Pharmaceutical Private Limited CIN U51909AS2011PTC010763 | Active | 08 Nov 2011 | Silchar, Assam | ₹1.9 Cr | – | 3 | View details |
Products & Services of Koronis
Koronis offers a comprehensive portfolio of products and services, including Health Products and Environmental Services.
Innovative products are supplied for health maintenance and disease prevention at affordable prices.
Environmental-friendly practices are implemented in product development to promote biodegradability and societal benefits.
Board of directors of Koronis Pharmaceutical Private Limited (Koronis)
Koronis Pharmaceutical Private Limited is the primary company behind Koronis. The board of Koronis Pharmaceutical Private Limited currently have 3 directors; the longest-serving is Geetopriyo Chokroborty, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Geetopriyo Chokroborty DIN 03619290 | Managing Director | 08 Nov 2011 | 14 yrs 11 mo | Koronis Pharmaceutical Private Limited |
| Gobinda K Chakravarty DIN 02065842 | Director | 17 Jul 2014 | 12 yrs 2 mo | Koronis Pharmaceutical Private Limited |
| Aparna Chakraborty DIN 06927690 | Director | 17 Jul 2014 | 12 yrs 2 mo | Koronis Pharmaceutical Private Limited |
Financials of Koronis
Figures of Koronis Pharmaceutical Private Limited, the primary company behind Koronis, for FY 2023. Revenue was ₹1.93 Cr (+9% year on year). Net profit was ₹0.06 Cr (3% margin). EBITDA was ₹0.10 Cr (5% margin). Revenue has grown at a compounded annual rate of +6% over three years and +4% over five years.
- ₹1.93 CrRevenue · FY 2023 · +9% YoY
- ₹0.06 CrNet profit · 3% margin
- ₹0.10 CrEBITDA · 5% margin
- ₹0.05 CrPaid-up capital
- +6%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Koronis Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Koronis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Koronis
10 companies that operate in the same segment as Koronis (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Koronis
Koronis was founded in 2013.
Koronis is headquartered in Zirakpur, India. It is registered at Zirakpur, Punjab, India.
The primary company behind Koronis, Koronis Pharmaceutical Private Limited, reported revenue of ₹1.93 Cr for FY 2023, up 9% year on year.
It is understood that Koronis Pharmaceutical is committed to supporting a disease-free India by providing an innovative range of products at affordable prices and superior quality. Responsibilities for a healthy environment are acknowledged, with environmental-friendly and biodegradable means being incorporated into operations. The organization focuses on expanding its product base while considering needs, affordability, utility, and benefits to society and the environment. Efforts are directed towards fostering a healthier tomorrow through these initiatives.
Koronis offers Health Products and Environmental Services.
Koronis operates through Koronis Pharmaceutical Private Limited.
The legal entities of Koronis currently have 3 directors, including Geetopriyo Chokroborty, Gobinda K Chakravarty, Aparna Chakraborty.